Eli Lilly is radically changing course after years of inflated prices and come the fourth quarter of this year, making their Humalog and Humulin, their state-of-the-art analog insulins, available for $ 35/month to those with private health insurance. We saw this happen earlier this year when Congress passed a bill capping monthly insulin at $ 35/month for … Continue reading Cost of a vial of Humalog will drop from $ 274.70 to $ 66.40 end of year
Diabetes Stories